
Enzana 40mg Capsule contains Enzalutamide, a medication used to treat prostate cancer that has spread or is resistant to standard hormone therapy.
| Composition | Enzalutamide |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 56 Capsules |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |




As a trusted supplier of high-quality generic anticancer medicines, we provide Enzana (Enzalutamide 40mg) Capsules, widely prescribed for the treatment of advanced prostate cancer.
We offer safe, consistent, and timely bulk supply of oncology medications, including Enzalutamide (Generic Xtandi), to hospitals, clinics, pharmacies, healthcare providers, physicians, NGOs, and authorized buyers worldwide. Our global distribution network spans over 80 countries across Latin America, Africa, Asia, Europe, the Middle East, and North America, covering major markets such as Mexico, Brazil, Colombia, Peru, Chile, UAE, Saudi Arabia, Egypt, South Africa, Namibia, Kenya, Nigeria, Singapore, Vietnam, Thailand, the Philippines, Canada, and many more.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.
Special pricing and offers available for bulk or long-term prescription purchases.
We source medicines directly from certified pharmaceutical manufacturers.
We support reshipments or refunds for undelivered, damaged, or incorrect orders.
Place your order through our website, WhatsApp, email, or by calling from anywhere in the world.
We coordinate with prescribing doctors (if needed) to ensure proper compliance and safety.
Customer care is available in English, Spanish, Russian, and other regional languages to assist global clients.